A sensitive method to quantify human cell-free circulating DNA in blood: Relevance to myocardial infarction screening

Clinical Biochemistry

Volumn 44, Issue 13, 2011, Pages 1074-1079

  Jing, Rong Rong ^a   Wang, Hui Min ^a   Cui, Ming ^a   Fang, Meng Kang ^a   Qiu, Xiao Jun ^a   Wu, Xin Hua ^a   Qi, Jin ^a   Wang, Yue Guo ^a   Zhang, Lu Rong ^b   Zhu, Jian Hua ^a   Ju, Shao Qing ^a  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Alu; Biomarkers; Branched DNA assay; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; CELL FREE DNA; CREATINE KINASE MB; DNA; MYOGLOBIN; TROPONIN I; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ALU SEQUENCE; ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DNA; FEMALE; HUMANS; MALE; MASS SCREENING; METHODS; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 80051700805     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.06.083     Document Type: Article

References (25)

1. Yeh R.W., Sidney S., Chandra M., et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010, 362:2155-2165.
2. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
3. Mandel P., Metais P. C R Seances. Soc Biol Fil 1948, 142:241-243.
4. Lim J.H., Kim M.J., Kim S.Y., et al. Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma. J Assist Reprod Genet 2011, 28:167-172.
5. Deligezer U., Yaman F., Darendeliler E., et al. Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clin Chim Acta 2010, 411:1452-1456.
6. Moreira V.G., Prieto B., Rodriguez J.S., et al. Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 2010, 47:253-258.
7. Pathak A.K., Bhutani M., Kumar S., et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006, 52:1833-1842.
8. Lavon I., Refael M., Zelikovitch B., et al. Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. Neuro Oncol 2010, 12:173-180.
9. Schwarzenbach H., Goekkurt E., Pantel K., et al. Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinoma. Int J Cancer 2010, 127:881-888.
10. Schwarzenbach H., Pantel K., Kemper B., et al. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res 2009, 11:R71.
11. Adrian K., Strouch M.J., Zeng Q., et al. Tgfbr1 haploinsufficiency inhibits the development of murine mutant Kras-induced pancreatic precancer. Cancer Res 2009, 69:9169-9174.
12. Kikuchi H., Pino M.S., Zeng M., et al. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Cancer Res 2009, 69:8499-8506.
13. Vlassov V.V., Laktionov P.P., Rykova E.Y. Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med 2010, 10:142-165.
14. Zheng Z., Luo Y., McMaster G.K. Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem 2006, 52:1294-1302.
15. Hwu H.R., Roberts J.W., Davidson E.H., et al. Insertion and/or deletion of many repeated DNA sequences in human and higher ape evolution. Proc Natl Acad Sci USA 1986, 83:3875-3879.
16. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
17. Lee T.H., Montalvo L., Chrebtow V., et al. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 2001, 41:276-282.
18. Chiu R.W., Poon L.L., Lau T.K., et al. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001, 47:1607-1613.
19. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
20. Zhong X.Y., Burk M.R., Troeger C., et al. Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000, 96:991-996.
21. van Wijk I.J., de Hoon A.C., Jurhawan R., et al. Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 2000, 46:729-731.
22. Poon L.L., Leung T.N., Lau T.K., et al. Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 2000, 356:1819-1820.
23. Lui Y.Y., Chik K.W., Chiu R.W., et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002, 48:421-427.
24. Holdenrieder S., Burges A., Reich O., Spelsberg F.W., et al. DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann N Y Acad Sci 2008, 1137:162-170.
25. Fournie G.J., Martres F., Pourrat J.P., et al. Plasma DNA as cell death marker in elderly patients. Gerontology 1993, 39:215-221.